Practical aspects of immunoglobulin replacement

被引：10
作者：
Ballow, Mark [1 ,2 ]
机构：
[1] Univ S Florida, Morsani Coll Med, Dept Pediat, Div Allergy & Immunol, 140 Seventh Ave S, St Petersburg, FL 33701 USA
[2] Johns Hopkins All Childrens Hosp, 140 Seventh Ave S, St Petersburg, FL 33701 USA
来源：
ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY | 2017年 / 119卷 / 04期
关键词：
FACILITATED SUBCUTANEOUS INFUSION; PRIMARY IMMUNODEFICIENCY; INTRAVENOUS IMMUNOGLOBULIN; ANTIBODY DEFICIENCIES; THERAPY; DISEASE; HYPOGAMMAGLOBULINEMIA; AGAMMAGLOBULINEMIA; EFFICACY; SAFETY;
D O I：
10.1016/j.anai.2017.07.020
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
[No abstract available]
引用
收藏
页码：299 / 303
页数：5
相关论文
共 21 条
  • [1] Increased risk of adverse events when changing intravenous immunoglobulin preparations
    Ameratunga, R
    Sinclair, J
    Kolbe, J
    [J]. CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2004, 136 (01) : 111 - 113
  • [2] Bioavailability of IgG Administered by the Subcutaneous Route
    Berger, Melvin
    Jolles, Stephen
    Orange, Jordan S.
    Sleasman, John W.
    [J]. JOURNAL OF CLINICAL IMMUNOLOGY, 2013, 33 (05) : 984 - 990
  • [3] Incidence of Infection is Inversely Related to Steady-State (Trough) Serum IgG Level in Studies of Subcutaneous IgG in PIDD
    Berger, Melvin
    [J]. JOURNAL OF CLINICAL IMMUNOLOGY, 2011, 31 (05) : 924 - 926
  • [4] Pharmacokinetics of subcutaneous immunoglobulin and their use in dosing of replacement therapy in patients with primary immunodeficiencies
    Berger, Melvin
    Rojavin, Mikhail
    Kiessling, Peter
    Zenker, Othmar
    [J]. CLINICAL IMMUNOLOGY, 2011, 139 (02) : 133 - 141
  • [5] Biologic IgG level in primary immunodeficiency disease: The IgG level that protects against recurrent infection
    Bonagura, Vincent R.
    Marchlewski, Robert
    Cox, Amanda
    Rosenthal, David W.
    [J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2008, 122 (01) : 210 - 212
  • [6] Prospective audit of adverse reactions occurring in 459 primary antibody-deficient patients receiving intravenous immunoglobulin
    Brennan, VM
    Salomé-Bentley, NJ
    Chapel, HM
    [J]. CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2003, 133 (02) : 247 - 251
  • [7] Children and adults with primary antibody deficiencies gain quality of life by subcutaneous IgG self-infusions at home
    Gardulf, A
    Nicolay, U
    Asensio, O
    Bernatowska, E
    Böck, A
    Costa-Carvalho, BT
    Granert, C
    Haag, S
    Hernández, D
    Kiessling, P
    Kus, J
    Matamoros, N
    Niehues, T
    Schmidt, S
    Schulze, I
    Borte, M
    [J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2004, 114 (04) : 936 - 942
  • [8] Efficacy and safety of Hizentra® in patients with primary immunodeficiency after a dose-equivalent switch from intravenous or subcutaneous replacement therapy
    Jolles, S.
    Bernatowska, E.
    de Gracia, J.
    Borte, M.
    Cristea, V.
    Peter, H. H.
    Belohradsky, B. H.
    Wahn, V.
    Neufang-Hueber, J.
    Zenker, O.
    Grimbacher, B.
    [J]. CLINICAL IMMUNOLOGY, 2011, 141 (01) : 90 - 102
  • [9] Pulmonary abnormalities in patients with primary hypogammaglobulinemia
    Kainulainen, L
    Varpula, M
    Liippo, K
    Svedström, E
    Nikoskelainen, J
    Ruuskanen, O
    [J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1999, 104 (05) : 1031 - 1036
  • [10] HIGH-DOSE VS LOW-DOSE IMMUNOGLOBULIN THERAPY IN THE LONG-TERM TREATMENT OF X-LINKED AGAMMAGLOBULINEMIA
    LIESE, JG
    WINTERGERST, U
    TYMPNER, KD
    BELOHRADSKY, BH
    [J]. AMERICAN JOURNAL OF DISEASES OF CHILDREN, 1992, 146 (03): : 335 - 339
123